Download PDF
Pneumologie 2017; 71(02): 117-120
DOI: 10.1055/s-0042-124568
Letter to the Editor
© Georg Thieme Verlag KG Stuttgart · New York

Only One Lesson to be Learned

Reply to X. Baur: Pneumologie 2016; 70: 405–412
Rolf Merget
1   Institute for Prevention and Occupational Medicine of the German Social Accident Insurance, Institute of the Ruhr University (IPA), Bochum
,
Inke Feder
2   Institute of Pathology, Ruhr University, Bochum
,
Andrea Tannapfel
2   Institute of Pathology, Ruhr University, Bochum
› Author Affiliations
Further Information

Publication History

Publication Date:
21 February 2017 (online)

Also available at
   Permissions and Reprints

See also:

Asbestos: Socio-legal and Scientific Controversies and Unsound Science in the Context of the Worldwide Asbestos Tragedy – Lessons to be LearnedPneumologie 2016; 70(06): 405-412
DOI: 10.1055/s-0042-103580

See also:

Response to the Letter of R. Merget, I. Feder and A. TannapfelPneumologie 2017; 71(02): 121-123
DOI: 10.1055/s-0042-124569

Although we agree that the high numbers of diseases caused by asbestos worldwide and the consequences for individual patients merit the word “tragedy”, we wish to comment a few issues which represent the repeatedly [1] [2] [3] published opinions of Prof. Baur, but are not common scientific knowledge.

 

  • References

  • 1 Baur X, Letzel S, Nowak D. Ethik in der Arbeitsmedizin. Orientierungshilfe in ethischen Spannungsfeldern. Landsberg: ecomed Medizin; 2009
    Google Scholar
  • 2 Baur X. Asbestbedingte Erkrankungen. Kein Ende in Sicht. Dtsch Ärztebl 2016; 113: 1-4
    PubMedGoogle Scholar
  • 3 Baur X, Woitowitz HJ. Lungenkrebs als Berufskrankheit. Pneumologie 2016; 70: 510-513
    Article in Thieme ConnectPubMedGoogle Scholar
  • 4 Anonymus. Asbestos, asbestosis, and cancer: the Helsinki criteria for diagnosis and attribution. Scand J Work Environ Health 1997; 23: 311-316
    CrossrefPubMedGoogle Scholar
  • 5 Tannapfel A. Jahresbericht Deutsches Mesotheliomregister. 2014 available here: http://www.ruhr-uni-bochum.de/pathologie/mam/content/jahresbericht2014.pdf
    PubMedGoogle Scholar
  • 6 Roggli VL, Gibbs AR, Attanoos R. et al. Pathology of asbestosis- An update of the diagnostic criteria: Report of the asbestosis committee of the college of American pathologists and pulmonary pathology society. Arch Pathol Lab Med 2010; 134: 462-480
    CrossrefPubMedGoogle Scholar
  • 7 Churg A, Wright JL. Persistence of natural mineral fibers in human lungs: an overview. Environ Health Perspect 1994; 102 (Suppl. 05) 229-233
    CrossrefPubMedGoogle Scholar
  • 8 De Klerk NH, Musk AW, Williams V. et al. Comparison of measures of exposure to asbestos in former crocidolite workers from Wittenoom Gorge, W. Australia. Am J Ind Med 1996; 30: 579-587
    PubMedGoogle Scholar
  • 9 Finkelstein MM, Dufresne A. Inferences on the kinetics of asbestos deposition and clearance among chrysotile miners and millers. Am J Ind Med 1999; 35: 401-412
    CrossrefPubMedGoogle Scholar
  • 10 Dumortier P, Thimpont J, de Maertelaer V. et al. Trends in asbestos body counts in bronchoalveolar lavage fluid over two decades. Eur Respir J 2003; 22: 519-524
    CrossrefPubMedGoogle Scholar
  • 11 Nuyts V, Vanhooren H, Begyn S. et al. Asbestos bodies in bronchoalveolar lavage in the 21st century: a time-trend analysis in a clinical population. Occup Environ Med 2017; 74: 59-65
    PubMedGoogle Scholar
  • 12 Oberdörster G. Determinants of the pathogenicity of man-made vitreous fibers (MMVF). Int Arch Occup Environ Health 2000; 73: S60-S68
    CrossrefPubMedGoogle Scholar
  • 13 Barber CM, Wiggans RE, Young C. et al. UK asbestos imports and mortality due to idiopathic pulmonary fibrosis. Occup Med 2016; 66: 106-111
    CrossrefPubMedGoogle Scholar
  • 14 Attanoos RL, Alchami FS, Pooley FD. et al. Usual interstitial pneumonia in asbestos-exposed cohorts – concurrent idiopathic pulmonary fibrosis or atypical asbestosis?. Histopathology 2016; 69: 492-498
    CrossrefPubMedGoogle Scholar
  • 15 Murray HM. Statement. In: Minutes of Evidence, Appendices and Index. Departmental Committee on Compensation for Industrial Diseases. London: His Majesty’s Stationary Office; 1907
    Google Scholar
  • 16 Cooke WE. Fibrosis of the lungs due to the inhalation of asbestos dust. Brit Med J 1924; 2: 147
    CrossrefPubMedGoogle Scholar
  • 17 Cooke WE. Pulmonary asbestosis. Brit Med J 1927; 2: 1024
    CrossrefPubMedGoogle Scholar
  • 18 AWMF. Leitlinie „Diagnostik und Begutachtung asbestbedingter Berufskrankheiten“. Registernummer 002 – 038. 2010
    PubMedGoogle Scholar
  • 19 Wilken D, Velasco Garrido M, Manuwald U. et al. Lung function in asbestos-exposed workers, a systematic review and meta-analysis. J Occup Med Toxicol 2011; 6: 21
    CrossrefPubMedGoogle Scholar
  • 20 Monsó E, Tura JM, Pujadas J. et al. Lung dust content in idiopathic pulmonary fibrosis: a study with scanning electron microscopy and energy dispersive x ray analysis. Br J Ind Med 1991; 48: 327-331
    PubMedGoogle Scholar
  • 21 Yamamoto S. Histopathological features of pulmonary asbestosis with particular emphasis on the comparison with those of usual interstitial pneumonia. Osaka City Med J 1997; 43: 225-242
    PubMedGoogle Scholar
  • 22 Ausschuss für Gefahrstoffe. Begründung zur Exposition-Risiko-Beziehung für Asbest in Bekanntmachung zu Gefahrstoffen 910. Exposition-Risiko-Beziehung für Asbest. 2008 www.baua.de
    PubMedGoogle Scholar
  • 23 Van Cleemput J, De Raeve H, Verschakelen J. et al. The “gold standard” for past asbestos exposure. Am J Respir Crit Care Med 2002; 165: 134
    CrossrefPubMedGoogle Scholar
  • 24 Woitowitz HJ. Die Asbestkörperchentheorie ist tot. Deutsches Mesotheliomregister – was nun?. Zbl Arbeitsmed 2016; 66: 232
    CrossrefPubMedGoogle Scholar